Drugmakers are pledging to help revamp drug distribution and grapple with other obstacles to patient access to medicines in developing countries, the Financial Times reports. Prices aren't the issue, companies say, but rather infrastructure. Report
Drugmakers are pledging to help revamp drug distribution and grapple with other obstacles to patient access to medicines in developing countries, the Financial Times reports. Prices aren't the issue, companies say, but rather infrastructure. Report